Five new research groups for young scientists, the C.H.S. research groups, have taken up their work in basic biomedical research. To mark the occasion, the German Cancer Research Center (DKFZ) will hold a ceremony on 20 July 2012. The Chica and Heinz Schaller Foundation is funding the groups, who are dually affiliated with Heidelberg University's CellNetworks Cluster of Excellence and the DKFZ.
Prof. Dr. Otmar D. Wiestler, Chairman of the Management Board of DKFZ, will kick off the event, followed by a welcome address from Prof. Dr. Hans-Georg Kräusslich, chairman of the scientific advisory board of the C.H.S Foundation, coordinator of the Cluster of Excellence, and Managing Director of the Department of Infectious Diseases at Heidelberg University Hospital. Group leaders Dr. Steeve Boulant, Dr. Valery Grinevich, Dr. Grant Hansman, Dr. Thomas Jahn and Dr. Björn Tews will then briefly introduce the C.H.S. research groups. Nobel laureate Prof. Dr. Harald zur Hausen will deliver the keynote address, speaking on the "long road to success".
The C.H.S. research groups are supported by the Chica and Heinz Schaller Foundation for a period of five years. In addition to funding the position of group leader, the foundation also provides funds for one postdoctoral researcher, one doctoral candidate, and one technical assistant. Funds are also made available for equipment and materials. The research groups were established between October 2011 and April 2012 at the Cluster of Excellence CellNetworks and the German Cancer Research Center. "Our aim is to strengthen basic biomedical research in Heidelberg, especially in the fields of infectious diseases and the neurosciences", notes founder Prof. Dr. Chica Schaller. After an international call for proposals, five outstanding young researchers, who previously worked in Japan, the USA, Great Britain, and Switzerland, amongst others, were recruited to Heidelberg University and the DKFZ.
Dr. Boulant's group is investigating the molecular mechanisms used by intestinal cells to defend against viral infections. Dr. Grinevich and his team are analysing neuropeptides of the vegetative nervous system that play a role in stress, fear and love. Noroviruses, causative agents of intestinal infections, are being explored by Dr. Hansman and his colleagues. This research group is studying virus structure to identify targets for antiviral medications. Dr. Jahn and his group are researching protein malfunctions that trigger neurodegenerative diseases. This work could lead to new approaches for the treatment of Alzheimer's disease. Dr. Tews and his team are focused on understanding the cellular signalling pathways underlying the invasive nature of aggressive brain tumour cells.
Research suggests no need for yellow fever vaccine booster after initial dose